{{Rsnum
|rsid=1882200
|Gene=IRAK3
|Chromosome=12
|position=66203921
|Orientation=plus
|GMAF=0.2199
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IRAK3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.6 | 46.0 | 12.4
| HCB | 72.1 | 26.5 | 1.5
| JPT | 75.0 | 23.2 | 1.8
| YRI | 69.4 | 28.5 | 2.1
| ASW | 63.2 | 36.8 | 0.0
| CHB | 72.1 | 26.5 | 1.5
| CHD | 75.9 | 21.3 | 2.8
| GIH | 65.3 | 31.7 | 3.0
| LWK | 67.6 | 27.8 | 4.6
| MEX | 71.4 | 25.0 | 3.6
| MKK | 65.2 | 31.6 | 3.2
| TSI | 45.5 | 46.5 | 7.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1882200
|Name_s=
|Gene_s=IRAK3
|Feature=
|Evidence=PubMed ID:17503328
|Annotation=rs1882200 was found by transmission/disequilibrium test and case-control analysis of families from Sardinia and mainland Italy to be associated with susceptibility to Early-Onset Persistent Asthma.
|Drugs=
|Drug Classes=
|Diseases=Asthma
|Curation Level=Curated
|PharmGKB Accession ID=PA162191381
}}

{{PMID|19264973|OA=1
}} Assessing the reproducibility of asthma candidate gene associations, using genome-wide data.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1882200
|overall_frequency_n=2675
|overall_frequency_d=10758
|overall_frequency=0.248652
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}